SECsense Logo

ESSA Pharma Inc. 8-K Report: Key Insights and Updates from December 2024

$EPIX
Form 8-K
Filed on: 2024-12-17
Source
ESSA Pharma Inc. 8-K Report: Key Insights and Updates from December 2024

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: ESSA Pharma Inc.
  • CIK Number: 0001633932
  • SEC File Number: 001-37410
  • Tax ID: 98-1250703
  • Address: Suite 720, 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5
  • Phone Number: 778-331-0962
  1. Filing Type:
  • Form Type: 8-K, indicating a current report that is used to inform investors of significant events.
  1. Filing Date:
  • Date of Report: December 17, 2024.
  1. Security Information:
  • Type of Security: Common Shares
  • Share Attributes: No par value
  • Ticker Symbol: EPIX
  • Exchange: NASDAQ
  1. Context and Unit Information:
  • Context ID: As of December 17, 2024.
  • Currency: USD (United States Dollar)
  • Unit for Shares: Shares
  • Measurement Units:
    • USD
    • Shares
    • USD per Share

Insights:

  • The report is a significant disclosure from ESSA Pharma Inc., as indicated by the use of Form 8-K, which typically includes information that could influence the company's stock price or investor decisions.
  • The fact that the company is listed on NASDAQ suggests it is being scrutinized by a wide array of investors and analysts, making transparency critical.
  • The filing date indicates the information is current and likely pertains to recent developments or financial results.
  • The absence of par value shares indicates flexibility in capital raising strategies for the company.

This information can help investors understand the current status and corporate governance of ESSA Pharma Inc., especially in relation to recent events that could impact its operations or stock performance.